The provincial government has added coverage for two drugs used to treat multiple sclerosis under its Prescription Drug Program.
The two drugs, Tysabri and Lemtrada, are administered through the use of an IV and are primarily dispensed through community pharmacies for use outside an acute care facility.
Government explains that, historically, drugs requiring an IV were excluded from the program because the administration could only occur in an acute care setting, and as such would have been free to patients. However, in recent years an increasing number of such drugs are being administered through private infusion clinics in the community.
They say adding the medications to the program will ensure consistency of coverage regardless of the setting in which they are administered.